Although the relationship between HIF-1α and drug resistance in breast cancer has been emphasized above, the mechanisms by which it induces resistance in chemotherapy, endocrine therapy, and targeted therapy remain to be clarified. The gene discussed is HIF1A; the disease is breast carcinoma.